Morphine is commonly used to treat bone pain associated with metastatic cancer, but research recently published in PAIN uncovered a mechanism by which chronic morphine use may increase bone loss and pain.

Current and former Australian firefighters say they are regularly exposed to carcinogens in fire stations. They are calling for the list of cancers covered under workers compensation laws to be expanded.

At the UArizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix, a team created a wig boutique for chemotherapy patients experiencing hair loss, which offered a sense of privacy and care for their emotional well-being.

A study published in the journal PAIN is the first to show how morphine interacts with toll-like receptor 4 to contribute to pain evolution and bone loss.

Health care system roadblocks often force transgender patients to obtain and self-administer gender-affirming hormones from unregulated, and oftentimes illegal, overseas online pharmacies instead of licensed medical offices.

Denise Moreno Ramirez, PhD, a postdoctoral scientist in the R. Ken Coit College of Pharmacy, writes an opinion column about the tendency of the beauty industry to expose women of color to products with toxic chemicals.

Cyltezo, a biosimilar version of top-selling Crohn's disease medication Humira, was released July 1. Several other similar drugs are also on the way.

Global health care coalition arises to bridge the gaps in underserved nations and help people receive needed chronic illness care.

Sources of stress for retirees include a grab bag of fears. There’s the potential loss of cognitive function, independence and loved ones. Fear of moving from a longtime home, getting a grim medical diagnosis or becoming a caregiver to an ailing partner can also stoke anxiety.